Articles On Medlab Clinical (ASX:MDC)

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AMX)) - Aerometrex ((AGI)) - Ainsworth Game Technology ((ALX)) - Atlas Arteria ((AUA)) - Audeara ((AMI)) - Aurelia Metals ((AVG)) - Australian Vintage ((DEL)) - Delorean...

Researchers say data shows transition from illicit to legal use of cannabis Medicinal users are at 37%, compared to 2.5% in 2018 Regulations, quality control and costs still barriers for legal week users   New research from the University...

Ice-T is opening a cannabis dispensary in New Jersey this year Snoop Dogg’s venture capital firm led a seed funding round for TSUMo Snacks Incannex ramps up development and manufacturing of IHL-216A drug New Jersey has given Ice-T the gre...

Medlab Clinical’s protection of its NRGBiotic has been given a win with formal acceptance of a depression patent in Europe. Aussie biotech Medlab Clinical (ASX:MDC) has announce that  the European Patent Office has formalised acceptance of...

Medlab Clinical’s (MDC) patent for depression is formally accepted by the European Patent Office The depression patent secures work completed by Medlab in an Australia depression trial, specifically around certain drug substances and their...

Medlab Clinical’s NanoCelle technology is changing the way medicine is delivered for better patient outcomes. So, what exactly is NanoCelle and how is it set to improve medicine delivery?  Ensuring the active pharmaceutical ingredient (API...

ASX benchmark ends 0.6% ahead Peregrine’s gold rush slows, but still up more than 85% for the day The UK is looking awesome, if you’re a fan of recessions The ASX has had a pretty stable afternoon today, after the ASX 200 rose to a 0.5% g...

July a great month for stocks — ASX200 had its best month since March, Emerging Companies (XEC) gained an eye-watering +14% Copper explorer Cobre stands tall as broader mining and exploration sector wilts Standout sector was Buy Now Pay La...

It’s quarterlies season as the ASX market announcements page becomes increasingly flooded with lodgements. The last day for companies to submit reports is the last business day of the first month after the prior quarter. If they don’t, they...

Mysterious pink glow over Mildura Thailand businesses go nuts for CBD desserts and bubble tea ECS nabs $2m commercial loan facility to invest in new capacity ICYMI a mysterious pink glow above Mildura sent residents into a bit of a frenzy...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Sean Hall of Medlab Clinical speaks at the Switzer Small and Micro Cap Investor Strategy Day 2022.

ECS is selling its medicinal cannabis farm in Tasmania Crypto ATMs are now a thing in weed dispensaries in the US Zelira Therapeutics nabs regulatory approval in Germany for insomnia medication Ever fancied your own cannabis farm? Well, t...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Retail and independent cannabis lounges could be opening soon in Vegas Cann Group gets good manufacturing practice (GMP) licence for its Mildura facility Bod plans to launch a low dose CBD schedule 3 product into the Australian market  ...

Medlab clinical has laid out its road map to a dual listing on the Nasdaq to help open up greater access to capital pools and strengthen its position as an advanced biotech in the world’s largest market. The Australian biotech, which specia...

The ASX200 makes it four gains in a row The small cap index remains uninspired despite some strong individual performances HRL and 4DX deliver huge returns on Tuesday   The benchmark XJO is up by 0.6%. The little XEC index is not. The ASX...

University of South Australia research has shown promising results into Medlab’s key technology to improve delivery of medicines for greater effectiveness. Australian biotech Medlab Clinical (ASX:MDC), which specialises in nano-particle del...

The ASX200 is up for a 6-week high today of 2% today US and EU share markets were up 3% and 2.6% respectively on Friday The energy and tech sectors led the charge, followed by financials   Take your mind off rising inflation and surging i...

Aussie biotech Medlab Clinical (ASX:MDC) has just nailed a game-changing South East Asian distribution deal, opening the region up to its branded nutraceutical brands in the key target market. The Aussie-listed MDC, which specialises in usi...

ASX is set to open higher this morning US Fed Jerome Powell says a US recession is a ‘possibility’ Bitcoin slips below US$20k again, says get me off this ride The ASX is set to open higher by 0.40% this morning despite a fall on Wall Stre...

A Thai university says adding cannabis to chicken feed has positive results on meat and egg quality Aussie cannabis campaigner now a Member of the Order of Australia MGC Pharma’s CBD treatment proves effective against brain tumors   Chian...

Over the past decade, opioid-induced deaths were more likely to be due to prescription drugs than illegal drugs As scientists discover new ways to use the plant’s medicinal compounds, cannabis is seen as a possible solution to the opioid c...

Boston Beer Co launches cannabis iced tea in Canada University of Sydney says using CBD and driving is no worries Emyria reports positive Phase 1 study results for ultra-pure CBD capsule The Boston Beer Co is launching a line of cannabis-...

Highlights Medlab has added a new delivery path to its NanoCelle® Nasal nucleic acid (mRNA/SiRNA) program. NanoCelle® is a patented delivery platform of Medlab ® designed to address known medication problems. The NanoCelle® delivery p...

Actor Woody Harrelson has opened a cannabis store in West Hollywood Releaf has plans for a weed wellness retreat in Byron Bay Incannex wants to buy out APIRx   It’s not surprising that Woody Harrelson loves weed – the actor was actually...

Actor and cannabis farmer Jim Belushi is headlining the Grow Up Conference and Expo next month Franchise Global Health has established the first legal seedbank in Denmark Botanix nabs FDA Qualified Infection Disease Product designation for...

Central Banks have their fingers on the fun button this week, and the markets are pricing in the big push. The Emerging Companies Index (XEC) has been sunk on day dot, down 2.3%. The S&P/ASX 200 index was down 1.2% at 4.15pm, with this...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The TGA down-scheduled low dose CBD in February for over-the-counter sales without a prescription Currently no CBD drugs have been approved for sale in Australia Cann Group reckons S3 registration could open the door to millions of patient...

The ASX healthcare sector rebounds on back of $20 billion Ramsay Healthcare takeover bid Volpara founder and CEO steps into new role as female CEO takes the reins Medlab Clinical shares soar after UK trade deal for probiotic for patients...

US Seed Connect launched Cannabis Crypto Seed Headz NFT Washington launches week-long cannabis tax holiday Medlab clinical makes moves in the Northern Hemisphere with manufacturing deal Wednesday was 4/20 day – while it’s more of an unoff...

Medlab Clinical (ASX:MDC) has announced a northern hemisphere trade deal with the former contract manufacturer of NRGBiotic.

Highlights Medlab Clinical has signed a three-year deal with Cultech Limited for NRGBiotic. Cultech will continue exclusive manufacturing of NRGBiotic for its PRO-VEN range. The deal opens opportunities in the UK pharmacies and health...

Medlab Clinical share price is soaring ~13.40% today to 11 cents on the back of a trade deal with UK’s Cultech Limited for its NRGBiotic. Australian biotech Medlab Clinical (ASX:MDC) has opened up a massive new northern hemisphere trade fr...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

The NanoCBD will be the first of two CBD programs to be launched by Medlab into the UK market. Australian biotech Medlab Clinical (ASX:MDC) is ready to export its medicinal cannabis program, the NanoCBD, to the UK market. The company has be...

Medlab’s focus on improving patient outcomes is leading to a homegrown revolution in the way drug medications are effectively delivered to patients. Australian Biotech Medlab Clinical (ASX:MDC) is positioning itself for a milestone year aft...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

The ACIC says weed consumption increased in cities and regions ROO receives USA design patent approval for its Heat Exchange Probe EMD has launched its second ultra-pure CBD capsule, the EMD-RX7   The latest Australian Criminal Intelligen...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AIZ)) - Air New Zealand ((ART)) - Airtasker ((APX)) - Appen ((ALX)) - Atlas Arteria ((AIA)) - Auckland International Airport ((AMI)) - Aurelia Metals ((ACL)) - Australia...

Hemp farmers in New York have been given the go ahead to plant cannabis for the 2022 season. The legislation allows conditionally licensed cannabis farmers to grow weed, but they must meet certain requirements, including safe, sustainable a...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Highlights Australia reported 31,064 new COVID-19 cases in the last 24 hours, taking the total number of cases to 2,436,656. Fully vaccinated tourists and visa holders can travel to Australia from 21 February. Eligible Australian kids...

Medlab Clinical (ASX:MDC) says it has received 'Favourable Opinion' status from the UK Research Ethics Committee for the forthcoming NanaBis Phase 3 trial.

In December France banned the sale of hemp flower and leaf loaded with CBD, but the Conseil d’Etat provisionally overruled the decision on Wednesday – pending further examination of the order. Basically, the French court said that flowers...

Medlab Clinical (MDC) reports positive net operating cashflows for the December quarter of $645,000 Revenue at the half-year was $5.6 million, representing a 33 per cent growth from the previous corresponding period The company spent $851,...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

Sean Hall of Medlab Clinical speaks at the Switzer Small and Micro Cap Investor Strategy Day 2021.